InnoCare Pharma IPO: Valuation Easy to Swallow
InnoCare Pharma Ltd (9969 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
561 Views
InnoCare (čÆŗčÆå„å) IPO: Momentum Matters but Mind the Limited Upside
InnoCare launched book building to raise up to USD 288 million to list in Hong Kong.Ā In our previous notes, we have covered the companyās key...
572 Views
InnoCare (čÆŗčÆå„å) Pre-IPO: PHIP and Valuation Update
InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...
627 Views
InnoCare Pharma IPO Initiation: Promising Prognosis
InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
500 Views
ECM Weekly (2 Feb 2020) - Smoore, Innocare, Kilcoy Global, Mr. DIY
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. ECM...
660 Views